Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

NCT04786223 is registered in ClinicalTrials.gov with Val Lowe as lead sponsor.

NCT NCT04786223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04786223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
Lead sponsor
Val Lowe
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
March 30, 2021
Completion date
March 31, 2030
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia (ad), lewy body dementia (lbd)